{"id":"https://openalex.org/W2936655556","doi":"https://doi.org/10.1097/ftd.0000000000000639","title":"Evaluation of Medication Adherence and Pharmacokinetics of Dasatinib for Earlier Molecular Response in Japanese Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Pilot Study","display_name":"Evaluation of Medication Adherence and Pharmacokinetics of Dasatinib for Earlier Molecular Response in Japanese Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Pilot Study","publication_year":2019,"publication_date":"2019-04-20","ids":{"openalex":"https://openalex.org/W2936655556","doi":"https://doi.org/10.1097/ftd.0000000000000639","mag":"2936655556","pmid":"https://pubmed.ncbi.nlm.nih.gov/31008998"},"language":"en","primary_location":{"id":"doi:10.1097/ftd.0000000000000639","doi":"https://doi.org/10.1097/ftd.0000000000000639","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000000639","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015379691","display_name":"Takuya Iwamoto","orcid":"https://orcid.org/0000-0002-6445-4410","observed_orcids":["https://orcid.org/0000-0002-6445-4410","https://orcid.org/0000-0001-5698-3841"]},"institutions":[{"id":"https://openalex.org/I4210116542","display_name":"Mie University Hospital","ror":"https://ror.org/01v9g9c07","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210116542"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takuya Iwamoto","raw_affiliation_strings":["Department of Pharmacy, Mie University Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Mie University Hospital;","institution_ids":["https://openalex.org/I4210116542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069168435","display_name":"Fumihiko Monma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I178574317","display_name":"Mie University","ror":"https://ror.org/01529vy56","country_code":"JP","type":"education","lineage":["https://openalex.org/I178574317"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumihiko Monma","raw_affiliation_strings":["Department of Hematology and Oncology, Mie University Graduate School of Medicine;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mie University Graduate School of Medicine;","institution_ids":["https://openalex.org/I178574317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083314957","display_name":"Kohshi Ohishi","orcid":"https://orcid.org/0000-0001-8136-9907","observed_orcids":["https://orcid.org/0000-0001-8136-9907"]},"institutions":[{"id":"https://openalex.org/I4210116542","display_name":"Mie University Hospital","ror":"https://ror.org/01v9g9c07","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210116542"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kohshi Ohishi","raw_affiliation_strings":["Department of Transfusion Medicine and Cell Therapy, Mie University Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Transfusion Medicine and Cell Therapy, Mie University Hospital;","institution_ids":["https://openalex.org/I4210116542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110817252","display_name":"Akira Umino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147193","display_name":"Yokkaichi Municipal Hospital","ror":"https://ror.org/03k36hk88","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210147193"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Akira Umino","raw_affiliation_strings":["Department of Hematology, Yokkaichi Municipal Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Yokkaichi Municipal Hospital;","institution_ids":["https://openalex.org/I4210147193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007670245","display_name":"Kei Suzuki","orcid":"https://orcid.org/0000-0002-2227-4737","observed_orcids":["https://orcid.org/0000-0002-2227-4737","https://orcid.org/0009-0006-6083-210X"]},"institutions":[{"id":"https://openalex.org/I4210116542","display_name":"Mie University Hospital","ror":"https://ror.org/01v9g9c07","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210116542"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kei Suzuki","raw_affiliation_strings":["Department of Emergency and Critical Care Center, Mie University Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Emergency and Critical Care Center, Mie University Hospital;","institution_ids":["https://openalex.org/I4210116542"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Koji Oka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405257724","display_name":"Suzuka Kaisei Hospital","ror":"https://ror.org/05kf0fr54","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405257724"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koji Oka","raw_affiliation_strings":["Department of Hematology, Suzuka Kaisei Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Suzuka Kaisei Hospital;","institution_ids":["https://openalex.org/I4405257724"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029993402","display_name":"Keiki Kawakami","orcid":"https://orcid.org/0000-0001-9729-8162","observed_orcids":["https://orcid.org/0000-0001-9729-8162"]},"institutions":[{"id":"https://openalex.org/I4405257577","display_name":"Suzuka Kosei Hospital","ror":"https://ror.org/05e0s9394","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405257577"]},{"id":"https://openalex.org/I4405284676","display_name":"Suzuka General Hospital","ror":"https://ror.org/040fkf973","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405284676"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Keiki Kawakami","raw_affiliation_strings":["Department of Hematology, JA Mie Suzuka General Hospital; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, JA Mie Suzuka General Hospital; and","institution_ids":["https://openalex.org/I4405257577","https://openalex.org/I4405284676"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109321584","display_name":"Takao Sekine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takao Sekine","raw_affiliation_strings":["Department of Internal Medicine, Matsusaka Chuo General Hospital, Mie, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Matsusaka Chuo General Hospital, Mie, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101569990","display_name":"Masahiro Okuda","orcid":"https://orcid.org/0000-0002-5517-0918","observed_orcids":["https://orcid.org/0000-0002-5517-0918"]},"institutions":[{"id":"https://openalex.org/I4210116542","display_name":"Mie University Hospital","ror":"https://ror.org/01v9g9c07","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210116542"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masahiro Okuda","raw_affiliation_strings":["Department of Pharmacy, Mie University Hospital;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Mie University Hospital;","institution_ids":["https://openalex.org/I4210116542"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103084164","display_name":"Naoyuki Katayama","orcid":"https://orcid.org/0000-0003-2170-9839","observed_orcids":["https://orcid.org/0000-0003-2170-9839"]},"institutions":[{"id":"https://openalex.org/I178574317","display_name":"Mie University","ror":"https://ror.org/01529vy56","country_code":"JP","type":"education","lineage":["https://openalex.org/I178574317"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoyuki Katayama","raw_affiliation_strings":["Department of Hematology and Oncology, Mie University Graduate School of Medicine;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Mie University Graduate School of Medicine;","institution_ids":["https://openalex.org/I178574317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5015379691","https://openalex.org/A5029993402","https://openalex.org/A5101569990"],"corresponding_institution_ids":["https://openalex.org/I4210116542","https://openalex.org/I4405257577","https://openalex.org/I4405284676"],"apc_list":null,"apc_paid":null,"fwci":0.5471,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.66069523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"41","issue":"5","first_page":"575","last_page":"581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9900000095367432},{"id":"https://openalex.org/keywords/major-molecular-response","display_name":"major molecular response","score":0.8240000009536743},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.7789999842643738},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5609999895095825},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.4790000021457672},{"id":"https://openalex.org/keywords/pleural-effusion","display_name":"pleural effusion","score":0.7739999890327454},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.47699999809265137},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9562045335769653},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8606805801391602},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6338464021682739},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5800068378448486},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.5769721865653992},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5713543891906738},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5622414946556091},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4965689778327942},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.48813995718955994},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4725639224052429},{"id":"https://openalex.org/C2779634585","wikidata":"https://www.wikidata.org/wiki/Q1334541","display_name":"Pleural effusion","level":2,"score":0.46820691227912903},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4462684690952301},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.4342377781867981},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.40299493074417114},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.34091877937316895},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10233938694000244}],"mesh":[{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002853","descriptor_name":"Chromatography, Liquid","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044466","descriptor_name":"Asian People","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053719","descriptor_name":"Tandem Mass Spectrometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/ftd.0000000000000639","doi":"https://doi.org/10.1097/ftd.0000000000000639","is_oa":false,"landing_page_url":"https://doi.org/10.1097/ftd.0000000000000639","pdf_url":null,"source":{"id":"https://openalex.org/S179268941","display_name":"Therapeutic Drug Monitoring","issn_l":"0163-4356","issn":["0163-4356","1536-3694"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Drug Monitoring","raw_type":"journal-article"},{"id":"pmid:31008998","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31008998","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic drug monitoring","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4793108695","display_name":"Development of novel preventive method for cisplatin-induced nephrotoxicity with drug-drug interaction","funder_award_id":"17K08412","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G5907234276","display_name":"Basic construction of WT1-targetting CAR-T therapy for acute myeloid leukemia","funder_award_id":"17K09923","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1968747503","https://openalex.org/W1971392962","https://openalex.org/W1978821257","https://openalex.org/W1981251869","https://openalex.org/W1994327535","https://openalex.org/W1999026822","https://openalex.org/W2011868643","https://openalex.org/W2013829602","https://openalex.org/W2018627521","https://openalex.org/W2028332702","https://openalex.org/W2032928509","https://openalex.org/W2058216377","https://openalex.org/W2093616162","https://openalex.org/W2097799776","https://openalex.org/W2140144216","https://openalex.org/W2143939343","https://openalex.org/W2148274830","https://openalex.org/W2163773009","https://openalex.org/W2166270808","https://openalex.org/W2346612065","https://openalex.org/W2412089478","https://openalex.org/W2502778732","https://openalex.org/W2556307127","https://openalex.org/W2609168040","https://openalex.org/W2735359179","https://openalex.org/W2800332303","https://openalex.org/W3193768044"],"related_works":["https://openalex.org/W2979375016","https://openalex.org/W4413939262","https://openalex.org/W2770793418","https://openalex.org/W2153481544","https://openalex.org/W2011868643","https://openalex.org/W2049696741","https://openalex.org/W2346612065","https://openalex.org/W100242696","https://openalex.org/W2482657298","https://openalex.org/W2414963949"],"abstract_inverted_index":{"BACKGROUND:":[0],"Tyrosine":[1],"kinase":[2],"inhibitors":[3],"markedly":[4],"improve":[5],"the":[6,28,86,91,133,147,162,183,187,191,211,258,266,270,278,292],"survival":[7],"for":[8,37,129,186,215,257,265],"patients":[9,52,121,143,222],"with":[10,53,144,233,309],"chronic":[11],"myeloid":[12],"leukemia":[13],"(CML).":[14],"However,":[15],"a":[16,47,288],"decrease":[17],"in":[18,146],"adherence":[19,84,128,264],"leads":[20],"to":[21,67,81,300,303],"undesired":[22],"therapeutic":[23],"outcomes.":[24],"In":[25],"this":[26,285],"study,":[27],"relationships":[29],"among":[30],"adherence,":[31],"pharmacokinetics,":[32],"response,":[33],"and":[34,61,85,106,114,168,205,231,269],"adverse":[35,239,312],"effects":[36],"dasatinib":[38,69,97,130,188,225,244,263,274,297],"treatment":[39,226],"were":[40,98,109,122],"prospectively":[41],"investigated.":[42],"METHODS:":[43],"This":[44],"study":[45,50,286],"was":[46,79,131,138,194,255,275],"prospective":[48],"cohort":[49],"of":[51,96,228,261,273,281,296],"newly":[54],"diagnosed":[55],"CML":[56,142],"at":[57,111],"4":[58],"general":[59],"hospitals":[60],"1":[62],"university":[63],"hospital.":[64],"Patients":[65],"started":[66],"receive":[68],"100":[70],"mg":[71],"once":[72],"daily.":[73],"A":[74,250],"Medication":[75,251],"Event":[76,252],"Monitoring":[77,253],"System":[78,254],"used":[80],"assess":[82],"medication":[83,87,127,135],"possession":[88,136],"ratio":[89,137],"during":[90],"12":[92,115,166],"months.":[93,174,220],"Plasma":[94],"concentrations":[95],"measured":[99],"using":[100],"liquid":[101],"chromatograph-tandem":[102],"mass":[103],"spectrometry":[104],"(LC-MS/MS),":[105],"therapy":[107],"responses":[108],"assessed":[110],"3,":[112],"6,":[113],"months":[116],"after":[117,242],"treatment.":[118],"RESULTS:":[119],"Ten":[120],"included.":[123],"An":[124],"extremely":[125],"high":[126],"observed;":[132],"median":[134],"99.4%.":[139],"All":[140],"9":[141],"breakpoints":[145],"major":[148,151,155],"BCR-ABL":[149,156],"achieved":[150,170],"molecular":[152,307],"response":[153,308],"(MMR;":[154],"transcript":[157],"level":[158],"below":[159],"0.1%":[160],"on":[161],"International":[163],"Scale)":[164],"within":[165,172,218],"months,":[167],"5":[169],"MMR":[171,217],"6":[173,219],"The":[175],"receiver":[176,206],"operating":[177,207],"characteristic":[178,208],"curve":[179,193,213],"analysis":[180],"revealed":[181],"that":[182],"cutoff":[184],"value":[185],"area":[189],"under":[190,210,277],"concentration-time":[192,212],"336.1":[195],"ng":[196],"\u00d7":[197],"h/mL":[198],"(accuracy":[199],"88.9%,":[200],"sensitivity":[201],"80.0%,":[202],"specificity":[203],"100%,":[204],"curve-area":[209],"0.800)":[214],"achieving":[216],"Two":[221],"had":[223,287],"interrupted":[224],"because":[227],"pleural":[229],"effusion":[230],"diarrhea":[232],"intestinal":[234],"edema,":[235],"respectively.":[236],"These":[237],"edematous":[238,311],"events":[240],"developed":[241],"plasma":[243,293],"Cmin":[245],"surpassed":[246],"3.0":[247],"ng/mL.":[248],"CONCLUSIONS:":[249],"applied":[256],"direct":[259],"evaluation":[260],"oral":[262],"first":[267],"time,":[268],"clinical":[271],"effect":[272],"investigated":[276],"strict":[279],"monitoring":[280,295],"patient":[282],"adherence.":[283],"Although":[284],"small":[289],"sample":[290],"size,":[291],"concentration":[294],"is":[298],"considered":[299],"be":[301],"useful":[302],"predict":[304],"an":[305],"earlier":[306],"fewer":[310],"events.":[313]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2019-04-25T00:00:00"}